NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
LOS ANGELES — April 9, 2018 — BLVD Centers Corporation (“BLVD” or the “Company”) (TSXV:CXV), a leading company in the United States addiction lifestyle management space, today announced its Weedaide™ line of marijuana lifestyle management products are available immediately for preorder on its website. The website can be found at www.weedaide.com.
“I’m very pleased that we are now in the position to begin selling our Weedaide™ products,” said Chris Heath, Chief Executive Officer. “While our addiction treatment business has grown in both revenue and profit over the last year, this is a tremendous opportunity to expand our product offering and enter the U.S. cannabis market through the treatment of marijuana side effects.”
“I’ve seen the initial excitement in the local community for our product, and with its margins and scalability, I believe this can become a national product,” continued Mr. Heath. “We have the ability to quickly scale to market demand, and as the first to market, we have very little competition. My goal is to not only use Weedaide™ to improve revenue, profit, and the lives of marijuana users, but also to establish relationships nationally with U.S. cannabis dispensaries. It is my belief that these relationships will prove to be invaluable as we continue to look for ways to monetize promising marijuana strains.”
The Company further announced that the Weedaide™ product line is expected to be available for delivery in late April through the website and through other distribution mediums.
“I firmly believe that there is an exceptional opportunity in this rapidly growing market for BLVD Centers,” continued Mr. Heath. “In our continued contact with stakeholders and potential affiliates we have continued to see high levels of interest in our Weedaide™ products and their performance in the market. I am excited to be able to share how the sales of the Weedaide™ products proceed with the markets shortly.”
Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, including: the Company believing that Weedaide™ can become a national product; Weedaide™ improving revenue and profit; the Company establishing new relationships nationally with U.S. cannabis dispensaries; the Company being successful in finding ways to monetize marijuana strains; are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information, including: BLVD securing trademarks for its products; BLVD executing agreements with distributors and retailers for its products; the commercial success of Weedaide™; no adverse changes to local, state and federal laws; and market reception of the Weedaide™ products. There is no guarantee that the Company’s plans to (i) sell products designed to reduce the side effects of daily marijuana use, (ii) generate significant revenue through Weedaide™ products (iii) launch very quickly and sell through multiple channels soon. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: changes in law; the ability to implement business strategies and pursue business opportunities; the state of the capital markets; the availability of funds and resources to pursue operations; decline of reimbursement rates; dependence on few payors; possible new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and licenses in a highly regulated business; competition; changes in healthcare regulations or insurance coverage, particularly those relating to mental health or younger citizens; difficulty integrating newly acquired businesses; the time, outcome and cost of any inquiries, audits or litigation with insurance providers, or federal, state or local regulators; low profit market segments; fluctuations in exchange rates; as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company’s disclosure documents filed with the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
BLVD Centers Corporation
Chief Executive Officer